Prolonged Partial Response to Osimertinib after Disease Progression to Rociletinib in Metastasic EGFR T790M-Positive Non-Small Cell Lung Cancer

Martinez Vila Clara; Garcia Garcia Yolanda; Carcereny Costa Enric

首页> 外文期刊>Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer >Prolonged Partial Response to Osimertinib after Disease Progression to Rociletinib in Metastasic EGFR T790M-Positive Non-Small Cell Lung Cancer

【24h】

Prolonged Partial Response to Osimertinib after Disease Progression to Rociletinib in Metastasic EGFR T790M-Positive Non-Small Cell Lung Cancer

机译：在转移EGFR T790M阳性非小细胞肺癌中患疾病进展后患疾病进展的患者患者的部分反应延长部分反应

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer》 |2018年第5期|共3页
作者
Martinez Vila Clara; Garcia Garcia Yolanda; Carcereny Costa Enric;
展开▼
作者单位

Hlth Corp Parc Tauli Sabadell Spain;

Hlth Corp Parc Tauli Sabadell Spain;

Hlth Corp Parc Tauli Sabadell Spain;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. Prolonged Partial Response to Osimertinib after Disease Progression to Rociletinib in Metastasic EGFR T790M-Positive Non-Small Cell Lung Cancer [J] . Martinez Vila Clara, Garcia Garcia Yolanda, Carcereny Costa Enric Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer . 2018,第5期

机译：在转移EGFR T790M阳性非小细胞肺癌中患疾病进展后患疾病进展的患者患者的部分反应延长部分反应
2. Osimertinib (AZD9291) and CNS Response in Two Radiotherapy-Naive Patients with EGFR-Mutant and T790M-Positive Advanced Non-Small Cell Lung Cancer [J] . Ricciuti Biagio, Chiari Rita, Chiarini Pietro, Clinical drug investigation . 2016,第8期

机译：Osimertinib（AZD9291）和CNS在两名未接受EGFR突变和T790M阳性的晚期非小细胞肺癌初治患者中的反应
3. P3.02b-115 Clinical Activity of Osimertinib in EGFR Mutation Positive Non-Small Cell Lung Cancer (NSCLC) Patients (Pts) Previously Treated with Rociletinib [J] . Shirish Gadgeel, Wei Chen, Zofia Piotrowska, Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer . 2017,第1期

机译：P3.02b-115 Esimertinib在EGFR突变阳性非小细胞肺癌（NSCLC）患者（PTS）中的临床活性以前用Rociletinib治疗
4. Development and validation of a radiomics nomogram for progression-free survival prediction in stage IV EGFR-mutant non-small cell lung cancer [C] . Jiangdian Song, Yali Zang, Weimin Li, Conference on Computer-Aided Diagnosis . 2017

机译：放射组学诺模图的开发和验证，用于IV期EGFR突变非小细胞肺癌的无进展生存期预测
5. Effects of TNFAIP8 knockdown on EGFR and IGF-1R signaling and cytotoxicities of targeted drugs in non-small cell lung cancer cells [D] . Day, Timothy Francis 2015

机译：TNFAIP8组合对非小细胞肺癌细胞EGFR和IGF-1R信号传导及靶向药物的细胞毒性的影响
6. Interstitial Lung Disease Induced by Osimertinib for Epidermal Growth Factor Receptor (EGFR) T790M-positive Non-small Cell Lung Cancer [O] . Yoshiya Matsumoto, Tomoya Kawaguchi, Norio Yamamoto, 2017

机译：奥西替尼诱导的表皮生长因子受体（EGFR）T790M阳性非小细胞肺癌间质性肺疾病
7. The Allele Frequency of EGFR Mutations Predicts Survival in Advanced EGFR T790M-Positive Non-small Cell Lung Cancer Patients Treated with Osimertinib [O] . Anna Buder, Maximilian J. Hochmair, Martin Filipits 2020

机译：EGFR突变的等位基因频率预测了由Osimertinib治疗的晚期EGFR T790M阳性非小细胞肺癌患者的存活

Prolonged Partial Response to Osimertinib after Disease Progression to Rociletinib in Metastasic EGFR T790M-Positive Non-Small Cell Lung Cancer

著录项

相似文献

相关主题

期刊订阅